Epigene Labs

Curated by Signal

Developer of drugs through precision oncology

Overview

Epigene Labs is focusing on genomics-driven drug design for precision oncology. The precision oncology platform uses AI technology to analyze the genomic data to identify, design and develop therapeutics for treating cancer.

Key facts

Founded: 2018
Headquarters: Paris, France
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

NeuroKyma
Developer of EEG-based neuro markers for detecting brain activity
Life Sciences TechnologyFrance
InstaDreamer
Provider of smart biosensor band for sleep monitoring
Life Sciences TechnologyFrance
Neurallys
Developing a device for the treatment of Hydrocephalus
Life Sciences TechnologyParis, France

About Epigene Labs

What does Epigene Labs do?

Epigene Labs is focusing on genomics-driven drug design for precision oncology.

Where is Epigene Labs headquartered?

Epigene Labs is headquartered in Paris, France.

When was Epigene Labs founded?

Epigene Labs was founded in 2018.

Which sector is Epigene Labs in?

Epigene Labs operates in Life Sciences Technology.

Who are Epigene Labs's competitors?

Companies similar to Epigene Labs include NeuroKyma, InstaDreamer, and Neurallys.